Cargando…
Personalized antiplatelet therapy with P2Y(12) receptor inhibitors: benefits and pitfalls
Antiplatelet therapy with P2Y(12) receptor inhibitors has become the cornerstone of medical treatment in patients with acute coronary syndrome, after percutaneous coronary intervention and in secondary prevention of atherothrombotic events. Clopidogrel used to be the most broadly prescribed P2Y(12)...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Termedia Publishing House
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679793/ https://www.ncbi.nlm.nih.gov/pubmed/26677375 http://dx.doi.org/10.5114/pwki.2015.55596 |